FTC says Shkreli violated lifetime pharma ban
The gist
The FTC and seven states asked a judge to hold Martin Shkreli in contempt.
The case tests whether a lifetime pharma ban can cover livestreamed stock trading.
How it unfolded
- 2015As Turing Pharmaceuticals CEO, Shkreli raised the price of Daraprim to $750 per tablet from $17.50 and appeared unapologetic when criticized; he was later arrested.
- 2017Shkreli was convicted on eight counts including securities fraud, and was jailed after a Facebook post about acquiring Hillary Clinton's hair that the Secret Service took as a threat.
- 2018Shkreli was sentenced to seven years in federal prison.